Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Geiger

Showing results (171-180 of 227) with videos related to

Pageof 23
Sort By:
Immunity|May 10, 2016
Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary GlandsVictor S Cortez, Luisa Cervantes-Barragan, Michelle L Robinette, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 20, 2014
Bispecificity for myelin and neuronal self-antigens is a common feature of CD4 T cells in C57BL/6 miceLiliana E Lucca, Sabine Desbois, Abdulraouf Ramadan, et al.
Hospital Pediatrics|July 16, 2016
Developing the Capacity for Rapid-Cycle Improvement at a Large Freestanding Children's HospitalEvan S Fieldston, Jennifer A Jonas, Virginia A Lederman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Imaging Extranodal Extension (iENE) Predicts Higher Rates of Distant Recurrence for Human Papillomavirus-Positive Oropharyngeal CancerCong Fan, Jonathan Lee, Sarah Stock, et al.
Anticancer Research|June 1, 2018
Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and ToxicityAditya Juloori, Shlomo A Koyfman, Jessica L Geiger, et al.
Head & Neck|April 25, 2024
Evaluating the impact of the degree of extranodal extension on outcomes in locally advanced oral cavity cancerAnirudh Yalamanchali, Christopher Griffith, Chandana A Reddy, et al.
Oral Oncology|June 1, 2017
IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancerL P Stabile, A M Egloff, M K Gibson, et al.
Anticancer Research|July 27, 2022
A Reappraisal of Definitive Chemoradiotherapy for Older Adults With Advanced Head and Neck CancerTimothy D Smile, Chandana A Reddy, Brian Matia, et al.
The Journal of Experimental Medicine|August 13, 2014
Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogensTheresa L Geiger, Michael C Abt, Georg Gasteiger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancerR L Ferris, J L Geiger, S Trivedi, et al.
Pageof 23

Showing results (171-180 of 227) with videos related to

Sort By:
Pageof 23
Immunity|May 10, 2016
Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary GlandsVictor S Cortez, Luisa Cervantes-Barragan, Michelle L Robinette, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 20, 2014
Bispecificity for myelin and neuronal self-antigens is a common feature of CD4 T cells in C57BL/6 miceLiliana E Lucca, Sabine Desbois, Abdulraouf Ramadan, et al.
Hospital Pediatrics|July 16, 2016
Developing the Capacity for Rapid-Cycle Improvement at a Large Freestanding Children's HospitalEvan S Fieldston, Jennifer A Jonas, Virginia A Lederman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Imaging Extranodal Extension (iENE) Predicts Higher Rates of Distant Recurrence for Human Papillomavirus-Positive Oropharyngeal CancerCong Fan, Jonathan Lee, Sarah Stock, et al.
Anticancer Research|June 1, 2018
Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and ToxicityAditya Juloori, Shlomo A Koyfman, Jessica L Geiger, et al.
Head & Neck|April 25, 2024
Evaluating the impact of the degree of extranodal extension on outcomes in locally advanced oral cavity cancerAnirudh Yalamanchali, Christopher Griffith, Chandana A Reddy, et al.
Oral Oncology|June 1, 2017
IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancerL P Stabile, A M Egloff, M K Gibson, et al.
Anticancer Research|July 27, 2022
A Reappraisal of Definitive Chemoradiotherapy for Older Adults With Advanced Head and Neck CancerTimothy D Smile, Chandana A Reddy, Brian Matia, et al.
The Journal of Experimental Medicine|August 13, 2014
Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogensTheresa L Geiger, Michael C Abt, Georg Gasteiger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancerR L Ferris, J L Geiger, S Trivedi, et al.
Pageof 23